Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials | TechCrunch
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.

Next post
This E Ink photo frame can double as your family’s digital dashboard
Related posts

Uber and Zipline's drone delivery service takes off in Texas, with dozens of cities to follow | TechCrunch
techcrunch.com

Meta launches Direct, a standalone messaging app for Instagram | TechCrunch
techcrunch.com

Voyage Labs raises $12 million for a specialized AI travel assistant | TechCrunch
techcrunch.com



